Next to the local treatment of lung diseases, the inhalative application route, e.g. for insulin therapy or against hypertension, has various advantages, as a faster treatment, higher efficacy and a reduced systemic side effect than other ways of administration [59]. The gene discussed is INS; the disease is lung disorder.